• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫介导获得性 LCAT 缺乏引起的肾病综合征。

Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

机构信息

Departments of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

J Am Soc Nephrol. 2013 Jul;24(8):1305-12. doi: 10.1681/ASN.2012090913. Epub 2013 Apr 25.

DOI:10.1681/ASN.2012090913
PMID:23620397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3736715/
Abstract

Lecithin-cholesterol acyltransferase (LCAT) is an enzyme involved in maintaining cholesterol homeostasis. In familial LCAT deficiency (FLD), abnormal lipid deposition causes renal injury and nephrotic syndrome, frequently progressing to ESRD. Here, we describe a 63-year-old Japanese woman with no family history of renal disease who presented with nephrotic syndrome. The laboratory data revealed an extremely low level of serum HDL and undetectable serum LCAT activity. Renal biopsy showed glomerular lipid deposition with prominent accumulation of foam cells, similar to the histologic findings of FLD. In addition, she had subepithelial electron-dense deposits compatible with membranous nephropathy, which are not typical of FLD. A mixing test and coimmunoprecipitation study demonstrated the presence of an inhibitory anti-LCAT antibody in the patient's serum. Immunohistochemistry and immunofluorescence detected LCAT along parts of the glomerular capillary walls, suggesting that LCAT was an antigen responsible for the membranous nephropathy. Treatment with steroids resulted in complete remission of the nephrotic syndrome, normalization of serum LCAT activity and HDL level, and disappearance of foam cell accumulation in renal tissue. In summary, inhibitory anti-LCAT antibody can lead to glomerular lesions similar to those observed in FLD.

摘要

卵磷脂胆固醇酰基转移酶(LCAT)是参与维持胆固醇稳态的一种酶。在家族性 LCAT 缺乏症(FLD)中,异常的脂质沉积会导致肾脏损伤和肾病综合征,常进展为终末期肾病。在这里,我们描述了一位 63 岁的日本女性,她没有肾脏疾病的家族史,表现为肾病综合征。实验室数据显示血清高密度脂蛋白极低,血清 LCAT 活性无法检测到。肾脏活检显示肾小球脂质沉积,有明显的泡沫细胞积聚,类似于 FLD 的组织学发现。此外,她还伴有符合膜性肾病的上皮下电子致密沉积物,这与 FLD 不典型。混合试验和共沉淀研究表明,患者血清中存在抑制性抗 LCAT 抗体。免疫组织化学和免疫荧光检测到 LCAT 存在于部分肾小球毛细血管壁上,表明 LCAT 是导致膜性肾病的抗原。皮质类固醇治疗导致肾病综合征完全缓解,血清 LCAT 活性和 HDL 水平正常化,肾脏组织中泡沫细胞积聚消失。综上所述,抑制性抗 LCAT 抗体可导致类似于 FLD 观察到的肾小球病变。

相似文献

1
Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.免疫介导获得性 LCAT 缺乏引起的肾病综合征。
J Am Soc Nephrol. 2013 Jul;24(8):1305-12. doi: 10.1681/ASN.2012090913. Epub 2013 Apr 25.
2
Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.免疫介导获得性卵磷脂-胆固醇酰基转移酶缺乏症:病例报告及文献复习。
J Clin Lipidol. 2018 Jul-Aug;12(4):888-897.e2. doi: 10.1016/j.jacl.2018.05.002. Epub 2018 May 15.
3
Familial LCAT deficiency in a child with nephrotic syndrome.一名肾病综合征患儿的家族性卵磷脂胆固醇酰基转移酶缺乏症
Clin Nephrol. 2014 Sep;82(3):211-4. doi: 10.5414/CN107928.
4
The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.载脂蛋白脂酶(LCAT)P274S 突变及其在一个大家系中的临床表现。
Am J Kidney Dis. 2019 Oct;74(4):510-522. doi: 10.1053/j.ajkd.2019.03.422. Epub 2019 May 15.
5
[Glomerulopathy associated with lecithin-cholesterol-acyltransferase deficiency: A case report and literature review].[卵磷脂胆固醇酰基转移酶缺乏相关的肾小球病:一例报告及文献复习]
Ann Pathol. 2019 Apr;39(2):172-176. doi: 10.1016/j.annpat.2018.09.005. Epub 2018 Dec 12.
6
Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli.卵磷脂:胆固醇酰基转移酶缺乏患者肾小球中氧化磷脂酰胆碱可能诱发肾功能障碍。
Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):794-801. doi: 10.1161/01.atv.19.3.794.
7
Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.编码序列无突变的卵磷脂胆固醇酰基转移酶(LCAT)缺乏症:一例报告及文献综述
Clin Nephrol. 2011 Oct;76(4):323-8. doi: 10.5414/cn106484.
8
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.原发性卵磷脂胆固醇脂酰转移酶缺乏症的自然史和生物标志物的系统评价。
J Lipid Res. 2022 Mar;63(3):100169. doi: 10.1016/j.jlr.2022.100169. Epub 2022 Jan 20.
9
Splenomegaly with sea-blue histiocytosis, dyslipidemia, and nephropathy in a patient with lecithin-cholesterol acyltransferase deficiency: a clinicopathologic correlation.一名患有卵磷脂胆固醇酰基转移酶缺乏症的患者出现脾肿大伴海蓝色组织细胞增多症、血脂异常和肾病:临床病理相关性研究
Metabolism. 2009 Oct;58(10):1459-64. doi: 10.1016/j.metabol.2009.04.033. Epub 2009 Jul 9.
10
A rare case of nephrotic syndrome and Tangier disease.一例罕见的肾病综合征合并 Tangier 病。
CEN Case Rep. 2023 Aug;12(3):265-269. doi: 10.1007/s13730-022-00761-8. Epub 2022 Dec 10.

引用本文的文献

1
Uncommon Factors Leading to Nephrotic Syndrome.导致肾病综合征的罕见因素。
Biomedicines. 2025 Aug 5;13(8):1907. doi: 10.3390/biomedicines13081907.
2
A Rare Case of Autoimmune-Mediated Lecithin:Cholesterol Acyltransferase Insufficiency Manifesting as the Acute Onset of Extremely Hypo-High-Density Lipoprotein-Cholesterolemia and Spontaneous Improvement: A Case Report with a Review of the Literature.一例罕见的自身免疫介导的卵磷脂胆固醇酰基转移酶缺乏症,表现为急性发作的极低高密度脂蛋白胆固醇血症并自发改善:病例报告及文献复习
J Atheroscler Thromb. 2025 May 1;32(5):649-659. doi: 10.5551/jat.65298. Epub 2024 Dec 10.
3
A rare case of nephrotic syndrome and Tangier disease.一例罕见的肾病综合征合并 Tangier 病。
CEN Case Rep. 2023 Aug;12(3):265-269. doi: 10.1007/s13730-022-00761-8. Epub 2022 Dec 10.
4
Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin-Cholesterol Acyltransferase Autoantibody.两例获得性高密度脂蛋白缺乏症伴免疫球蛋白 G4 相关卵磷脂胆固醇酰基转移酶自身抗体。
J Atheroscler Thromb. 2023 Aug 1;30(8):1070-1082. doi: 10.5551/jat.63616. Epub 2022 Nov 16.
5
A rare case of renal involvement in Lecithin-Cholesterol Acyltransferase (LCAT) deficiency: lessons for the clinical nephrologist.卵磷脂胆固醇酰基转移酶(LCAT)缺乏症累及肾脏的罕见病例:给临床肾科医生的启示
J Nephrol. 2023 Mar;36(2):319-321. doi: 10.1007/s40620-022-01459-x. Epub 2022 Sep 26.
6
Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia.整合脂质组学和网络药理学分析揭示小檗碱治疗高脂血症的作用机制。
J Transl Med. 2022 Sep 8;20(1):412. doi: 10.1186/s12967-022-03623-0.
7
LCAT deficiency and pregnancy: Case report.卵磷脂胆固醇酰基转移酶缺乏症与妊娠:病例报告
Obstet Med. 2021 Sep;14(3):193-196. doi: 10.1177/1753495X20950574. Epub 2020 Sep 9.
8
Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases.使用脂质修饰剂治疗肾小球疾病。
J Pers Med. 2021 Aug 21;11(8):820. doi: 10.3390/jpm11080820.
9
Current Status of Familial LCAT Deficiency in Japan.日本家族性 LCAT 缺乏症的现状。
J Atheroscler Thromb. 2021 Jul 1;28(7):679-691. doi: 10.5551/jat.RV17051. Epub 2021 Apr 18.
10
Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.与两名葡萄牙兄弟家族性卵磷脂胆固醇酰基转移酶缺乏症非典型表型相关的新型错义LCAT基因突变
JIMD Rep. 2018;40:55-62. doi: 10.1007/8904_2017_57. Epub 2017 Oct 6.

本文引用的文献

1
Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases.脂肪细胞作为离体基因治疗的载体:糖尿病及其他代谢性疾病的新型替代疗法。
J Diabetes Investig. 2011 Oct 7;2(5):333-40. doi: 10.1111/j.2040-1124.2011.00133.x.
2
Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma.非霍奇金淋巴瘤中与抗卵磷脂胆固醇酰基转移酶自身抗体相关的严重高密度脂蛋白缺乏症。
Arch Intern Med. 2012 Jan 23;172(2):179-81. doi: 10.1001/archinternmed.2011.661.
3
Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.卵磷脂:胆固醇酰基转移酶、高密度脂蛋白与人类的动脉粥样硬化保护
Trends Cardiovasc Med. 2010 Feb;20(2):50-3. doi: 10.1016/j.tcm.2010.03.007.
4
Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.重组人卵磷脂胆固醇酰基转移酶输注对小鼠脂蛋白代谢的影响。
J Pharmacol Exp Ther. 2010 Oct;335(1):140-8. doi: 10.1124/jpet.110.169540. Epub 2010 Jul 6.
5
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.膜性肾病中的自身免疫反应针对醛糖还原酶和 SOD2。
J Am Soc Nephrol. 2010 Mar;21(3):507-19. doi: 10.1681/ASN.2008121259. Epub 2010 Feb 11.
6
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
7
Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.卵磷脂:胆固醇酰基转移酶的表达对体内巨噬细胞逆向胆固醇转运的影响极小。
Circulation. 2009 Jul 14;120(2):160-9. doi: 10.1161/CIRCULATIONAHA.108.825109. Epub 2009 Jun 29.
8
Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.卵磷脂胆固醇酰基转移酶——从生物化学到在心血管疾病中的作用
Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):163-71. doi: 10.1097/med.0b013e328329233b.
9
The effect of lipoproteins on the development and progression of renal disease.脂蛋白对肾脏疾病发生发展的影响。
Am J Nephrol. 2008;28(5):723-31. doi: 10.1159/000127980. Epub 2008 Apr 24.
10
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.载脂蛋白A-I、ATP结合盒转运体A1、卵磷脂胆固醇酰基转移酶和清道夫受体B1在高密度脂蛋白生物合成中的作用。
J Mol Med (Berl). 2006 Apr;84(4):276-94. doi: 10.1007/s00109-005-0030-4. Epub 2006 Feb 25.